These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12023676)

  • 21. Re: Prospective reinfaction outcomes in the Thrombolytic Era Cardizem CD Trial (PROTECT).
    Goodman S; Langer A
    Can J Cardiol; 1997 Jul; 13(7):693, 696. PubMed ID: 9251584
    [No Abstract]   [Full Text] [Related]  

  • 22. [Differentiation and evaluation of calcium antagonists in therapy of arterial hypertension].
    Holzgreve H
    Internist (Berl); 2003 Apr; 44(4):483-90. PubMed ID: 12914406
    [No Abstract]   [Full Text] [Related]  

  • 23. Diltiazem: the latest calcium-channel blocker.
    Kesten KS; Reuter NS; Swisher JD
    Dimens Crit Care Nurs; 1984; 3(3):154-60. PubMed ID: 6562003
    [No Abstract]   [Full Text] [Related]  

  • 24. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Kjeldsen SE; Westheim AS; Os I
    Lancet; 2000 Dec; 356(9245):1929-30. PubMed ID: 11130406
    [No Abstract]   [Full Text] [Related]  

  • 25. [Indications for calcium channel antagonist therapy according to the latest large clinical trials].
    Kosicka T; Kara-Perz H; Głuszek J; Perz S
    Pol Arch Med Wewn; 2005 Dec; 114(6):1244-51. PubMed ID: 16789496
    [No Abstract]   [Full Text] [Related]  

  • 26. [Efficiency and safety of a long-lasting form of diltiazem in the treatment of hypertensive patients with ischemic heart disease].
    Svetyĭ LI; Pavlova LI; Mazerkina IA
    Klin Med (Mosk); 2002; 80(8):58-61. PubMed ID: 12360623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Improvement of postinfarct left myocardial contractile function after administration of diltiazem].
    Gambelli G; Donati R; Mezzanotte R; Pozzar F; Cesario AS; Schiavo B; Pau F
    G Ital Cardiol; 1998 Mar; 28(3):249-58. PubMed ID: 9561879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Topical diltiazem preparations for the treatment of anal fissures].
    Schaus V
    J Pharm Belg; 2013 Dec; (4):14-7. PubMed ID: 24449968
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium channel blocking agents. Council on scientific affairs.
    JAMA; 1983 Nov; 250(18):2522-4. PubMed ID: 6685194
    [No Abstract]   [Full Text] [Related]  

  • 31. INSIGHT and NORDIL. International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment. Nordic Diltiazem Study.
    Achard JM; Oudart N; Aldigier JC
    Lancet; 2000 Dec; 356(9245):1926-7; author reply 1928-9. PubMed ID: 11130401
    [No Abstract]   [Full Text] [Related]  

  • 32. [Calcium antagonists in the treatment of hypertension].
    Omae T
    Nihon Rinsho; 1989 Aug; 47(8):1794-8. PubMed ID: 2585743
    [No Abstract]   [Full Text] [Related]  

  • 33. ALLHAT and calcium channel blockers. ALLHAT Research Group.
    Proschan M; Davis B; Cutler J; Ford C; Furberg C; Grimm R; Oparil S
    Am J Hypertens; 1997 Jan; 10(1):142-3. PubMed ID: 9008261
    [No Abstract]   [Full Text] [Related]  

  • 34. Preventing hypotension effect of calcium channel blockers.
    Allen R
    Am Fam Physician; 2003 Mar; 67(5):940; author reply 940-1. PubMed ID: 12643354
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term treatment with calcium antagonists: advantageous effects and risks].
    van Zwieten PA; Tijssen JG; Lie KI; de Leeuw PW
    Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2715-21. PubMed ID: 8569884
    [No Abstract]   [Full Text] [Related]  

  • 36. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W; Cohen JD; Wolfson P; Davis A; Green S
    Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The unnecessary controversy or lack of knowledge?
    Fischer-Hansen J
    Eur Heart J; 1997 Jan; 18(1):167-8. PubMed ID: 9049531
    [No Abstract]   [Full Text] [Related]  

  • 39. Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension.
    Chan P; Lin CN; Tomlinson B; Lin TH; Lee YS
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):743-9. PubMed ID: 9234828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are calcium antagonists harmful in hypertensive patients? Distinguishing hype from reality.
    Habib GB
    Chest; 1995 Jul; 108(1):3-5. PubMed ID: 7606987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.